ProSciento Appoints Dr. Michael Grimm as Chief Medical Officer Read More »
ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH) Read More »
View Our Presentation
Clinical Research Considerations for Biosimilar Insulins Read More »
Specialized Expertise to Drive Advances in Diabetes Drug and Device Development Read More »
Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption Read More »
